Molecular imaging in breast cancer
- PMID: 23326265
- PMCID: PMC3544284
- DOI: 10.1155/2012/426260
Molecular imaging in breast cancer
References
-
- Luo T, Yan H-M, He P, Luo Y, Yang Y-F, Zheng H. Aspirin use and breast cancer risk: a meta-analysis. Breast Cancer Research and Treatment. 2012;131(2):581–587. - PubMed
-
- Dua SM, Gray RJ, Keshtgar M. Strategies for localisation of impalpable breast lesions. Breast. 2011;20(3):246–253. - PubMed
-
- Biglia N, Bounous VE, Martincich L, et al. Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast. European Journal of Surgical Oncology. 2011;37(3):199–204. - PubMed
-
- Meng Y, Ward S, Cooper K, Harnan S, Wyld L. Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer. European Journal of Surgical Oncology. 2011;37(1):40–46. - PubMed
-
- Koolen BB, ValdésOlmos RA, Elkhuizen PHM, et al. Locoregional lymph node involvement on 18F-FDG-PET/CT in breast cancer scheduled for noeadjuvant chemotherapy. Breast Cancer Research and Treatment. 2012;40:135–231. . In press. - PubMed
LinkOut - more resources
Full Text Sources
